Paying for Cell & Gene Therapy in the US: Is the Future Already Here?
Multiple novel payment models for CGT are currently deployed but an open and collaborative innovation approach among stakeholders is needed.
Vocal.
Paying for Cell & Gene Therapy in the US: Is the Future Already Here?
New approaches to pharma sales: Success is marrying data analytics with the art of 1-1 engagement
Innovative Financing for Cell and Gene Therapies
Key Trends in US Specialty Pharmacy. Payer Perspectives and Developer Strategies, 2020-23
AMCP Poster: A Systematic Comparison of Status Quo and Future Expectations for Novel Drug Financing
AMCP Poster: A Survey-Based Analysis of Formulary Decision Making and Utilization Management Trends
Netflix’s revenue model as a blueprint for pharmaceutical pricing?
The Rise of Cost Effectiveness Considerations in the US.
Can we afford to pay for future cures?